Cyp3a16 Inhibitors
Cyp3a16 inhibitors are a class of chemical compounds specifically designed to target and inhibit the activity of the Cyp3a16 enzyme, a member of the cytochrome P450 superfamily. The Cyp3a16 enzyme plays a significant role in the oxidative metabolism of a wide range of substrates, including endogenous molecules such as hormones, steroids, and fatty acids, as well as exogenous compounds like pharmaceuticals and environmental toxins. As a cytochrome P450 enzyme, Cyp3a16 functions by catalyzing the monooxygenation of these substrates, a process that introduces an oxygen atom into the substrate molecule. This oxidative transformation typically increases the solubility of the substrates, making them more amenable to further metabolic processes such as conjugation and excretion. The activity of Cyp3a16 is particularly critical in the liver, where it contributes to the detoxification of potentially harmful compounds and the regulation of various metabolic pathways.
Inhibitors of Cyp3a16 are generally small molecules that are designed to bind specifically to the active site of the enzyme, thereby preventing it from interacting with and oxidizing its natural substrates. These inhibitors may function by occupying the substrate-binding pocket, effectively blocking access to the catalytic site, or by inducing conformational changes that reduce the enzyme's catalytic efficiency. The development of Cyp3a16 inhibitors requires a detailed understanding of the enzyme's three-dimensional structure, particularly the regions involved in substrate recognition and catalytic activity. By inhibiting Cyp3a16, researchers can investigate the specific role of this enzyme in various metabolic processes and assess how its inhibition impacts the broader network of cytochrome P450-mediated reactions. The study of Cyp3a16 inhibitors is crucial for understanding the enzyme's substrate specificity, its interaction with other metabolic enzymes, and its overall contribution to maintaining metabolic homeostasis within the body. This research enhances our understanding of the diverse roles of cytochrome P450 enzymes and their importance in the metabolism and detoxification of a wide array of chemical entities in biological systems.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ketoconazole | 65277-42-1 | sc-200496 sc-200496A | 50 mg 500 mg | $62.00 $260.00 | 21 | |
Broad-spectrum antifungal agent known to inhibit Cyp3a16. By hindering the demethylase activity, it disrupts the oxidative demethylation process, contributing to indirect inhibition of the target protein within the endoplasmic reticulum. | ||||||
Clotrimazole | 23593-75-1 | sc-3583 sc-3583A | 100 mg 1 g | $41.00 $56.00 | 6 | |
Imidazole antifungal compound acting as an indirect inhibitor of Cyp3a16. It interferes with the steroid hydroxylase activity, impacting the steroid metabolic process and leading to indirect inhibition of the target protein within the endoplasmic reticulum. | ||||||
Fluconazole | 86386-73-4 | sc-205698 sc-205698A | 500 mg 1 g | $53.00 $84.00 | 14 | |
Azole antifungal compound acting as an indirect inhibitor of Cyp3a16. It disrupts the retinoic acid 4-hydroxylase activity, impacting the steroid metabolic process and contributing to the inhibition of the target protein within the endoplasmic reticulum. | ||||||
Miconazole | 22916-47-8 | sc-204806 sc-204806A | 1 g 5 g | $65.00 $157.00 | 2 | |
Imidazole antifungal agent acting as an indirect inhibitor of Cyp3a16. Through interference with the demethylase activity, it disrupts the oxidative demethylation process, leading to indirect inhibition of the target protein within the endoplasmic reticulum. | ||||||
Itraconazole | 84625-61-6 | sc-205724 sc-205724A | 50 mg 100 mg | $76.00 $139.00 | 23 | |
Triazole antifungal agent known to inhibit Cyp3a16. By interfering with the retinoic acid 4-hydroxylase activity, it impacts the steroid metabolic process, contributing to indirect inhibition of the target protein within the endoplasmic reticulum. | ||||||
Fluoxetine | 54910-89-3 | sc-279166 | 500 mg | $312.00 | 9 | |
Selective serotonin reuptake inhibitor acting as an indirect inhibitor of Cyp3a16. It disrupts the retinoic acid 4-hydroxylase activity, impacting the oxidative demethylation process and contributing to the inhibition of the target protein within the endoplasmic reticulum. | ||||||
Fluvoxamine | 54739-18-3 | sc-207697 | 25 mg | $315.00 | 1 | |
Selective serotonin reuptake inhibitor with inhibitory effects on Cyp3a16. By interfering with the steroid hydroxylase activity, it impacts the steroid metabolic process, contributing to indirect inhibition of the target protein within the endoplasmic reticulum. | ||||||
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $95.00 $322.00 $663.00 $1438.00 | 6 | |
Antibiotic known to induce Cyp3a16 activity. By enhancing the demethylase and steroid hydroxylase activities, it stimulates the oxidative demethylation and steroid metabolic processes, contributing to indirect activation of the target protein within the endoplasmic reticulum. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $76.00 $82.00 $367.00 | 36 | |
Synthetic glucocorticoid with inhibitory effects on Cyp3a16. By suppressing the steroid hydroxylase activity, it impacts the steroid metabolic process, contributing to indirect inhibition of the target protein within the endoplasmic reticulum. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $367.00 | ||
Calcium channel blocker known to inhibit Cyp3a16. By interfering with the steroid hydroxylase activity, it impacts the steroid metabolic process, contributing to indirect inhibition of the target protein within the endoplasmic reticulum. | ||||||